🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of acetaminophen, alleging the firms hid safety concerns that the medication presented to children's neurological development.

The court filing arrives a month after Donald Trump publicized an unsubstantiated connection between using acetaminophen - alternatively called acetaminophen - while pregnant and autism in young ones.

Paxton is taking legal action against Johnson & Johnson, which previously sold the medication, the sole analgesic suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he stated they "misled consumers by profiting off of discomfort and marketing drugs regardless of the potential hazards."

Kenvue states there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies misled for generations, deliberately risking countless individuals to line their pockets," the attorney general, from the Republican party, declared.

Kenvue said in a statement that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its website, the company also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that demonstrates a proven link between consuming paracetamol and autism."

Associations representing medical professionals and medical practitioners share this view.

ACOG has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for pregnant women to treat pain and fever, which can pose serious health risks if not addressed.

"In more than two decades of investigation on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of paracetamol in any period of gestation causes brain development issues in young ones," the group said.

The court filing references latest statements from the Trump administration in asserting the medication is potentially dangerous.

In recent weeks, the former president caused concern from public health officials when he instructed expectant mothers to "struggle intensely" not to use Tylenol when sick.

The US Food and Drug Administration then released a statement that physicians should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the medication and autism in young ones has not been established.

The Health Department head RFK Jr, who manages the FDA, had promised in April to conduct "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a matter of months.

But experts warned that discovering a unique factor of autism - believed by scientists to be the consequence of a intricate combination of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a type of enduring cognitive variation and disability that influences how individuals experience and interact with the world, and is diagnosed using doctors' observations.

In his legal document, Paxton - aligned with the former president who is running for federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around paracetamol and autism spectrum disorder.

The case aims to force the firms "eliminate any commercial messaging" that states acetaminophen is secure for pregnant women.

This legal action mirrors the grievances of a assembly of guardians of children with autism and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

The court threw out the legal action, saying investigations from the plaintiffs' authorities was inconclusive.